Table 4.
The rate of complication for rebiopsy in different factors (N = 113).
| Variables | Factors | Complication status | p-value | |
|---|---|---|---|---|
| Complication (n = 37) | Noncomplication (n = 76) | |||
| Age (year) | 59.0 ± 9.6 | 59.2 ± 10.9 | 0.891 | |
| Sex | Male | 24 (64.9%) | 30 (39.5%) | 0.011 |
| Female | 13 (35.1%) | 46 (60.5%) | ||
| Smoking status | Yes | 13 (35.1%) | 18 (23.7%) | 0.200 |
| No | 24 (64.9%) | 58 (76.3%) | ||
| History of lung surgery | Yes | 5 (13.5%) | 13 (17.1%) | 0.624 |
| No | 32 (86.5%) | 63 (82.9%) | ||
| ECOG performance status | 0-2 | 35 (94.6%) | 70 (92.1%) | 0.926 |
| 3-4 | 2 (5.4%) | 6 (7.9%) | ||
| Emphysema | Yes | 2 (5.4%) | 5 (6.6%) | 1.000 |
| No | 35(94.6%) | 71(93.4%) | ||
| Treatment history | TKI | 10 (27.0%) | 27 (35.5%) | 0.048 |
| Chemotherapy | 11 (29.8%) | 33 (43.4%) | ||
| TKI plus chemotherapy | 16 (43.2%) | 16 (21.1%) | ||
| Treatment time (M) | ≤ 15 | 18(48.6%) | 43(56.6%) | 0.427 |
| > 15 | 19(51.4%) | 33(43.4%) | ||
| Target lesion | Primary | 21 (56.8%) | 45 (59.2%) | 0.804 |
| Metastasis | 16 (43.2%) | 31 (40.8%) | ||
| Biopsy site | Upper lobe | 15 (40.5%) | 43 (56.6%) | 0.273 |
| Middle lobe | 3 (8.1%) | 5 (6.6%) | ||
| Lower lobe | 19 (51.4%) | 28 (36.8%) | ||
| Tumor size (cm) | ≤ 2 | 21 (56.8%) | 3 0 (39.5%) | 0.083 |
| > 2 | 16 (43.2%) | 46 (60.5%) | ||
| Biopsy method | Single needle | 12 (32.4%) | 15 (19.7%) | 0.138 |
| Coaxial technique | 25 (67.6%) | 61 (80.3%) | ||
| Transfissural approach | Yes | 6 (16.2%) | 2 (2.6%) | 0.024 |
| No | 31 (83.8%) | 74 (97.4%) | ||
| Pleura-to-target distance (cm) | ≤ 3 | 21 (56.8%) | 54 (71.1%) | 0.131 |
| > 3 | 16 (43.2%) | 22 (28.9%) | ||
| Total biopsy time (min) | ≤ 10 | 9 (24.3%) | 28 (36.8%) | 0.183 |
| > 10 | 28 (75.7%) | 48 (43.2%) | ||